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Background:  Vitamin D (Vit D) deficiency has been associated with cardiovascular (CV) disease. Vit D deficiency leads to secondary 
hyperparathyroidism, and both primary and secondary hyperparathyroidism are associated with CV pathology. Parathyroid hormone (PTH) is an 
important regulator of calcium homeostasis, and its impact on CV disease is of interest. We tested whether elevated PTH is associated with CV 
disease and whether risk depends on Vit D status.
Methods:  Subjects with measured PTH and Vit D levels were studied (N = 9369, age = 63±16 y, 36% male). PTH levels were defined as low (<15), 
normal (15-75), or elevated (>75 pg/mL). Prevalence and incidence of outcomes were determined by ICD-9 codes documented at baseline and 
during an average of 2.0 ± 1.5 y (max: 7.5 y) follow-up.
Results:  Baseline CV disease prevalence by PTH category is shown in Table 1A and incidence rates and their hazard ratios in Table 1B. Highly 
significant differential prevalence/incidence rates are noted across categories, specifically for PTH>75 pg/ml. PTH and Vit D correlated weakly 
(r=0.15). Vit D attenuated PTH risk associations only mildly and risk, though attenuated, persisted after adjustment.
Conclusions:  Elevated PTH is associated with greater CV prevalence and incidence, including mortality, during follow-up. Risk persists when 
adjusted for Vit D and standard risk factors. PTH represents an important new CV risk factor that adds complementary and independent value to 
prediction of CV disease and mortality.
